TCG GreenChem Inc.’s Post

As the sun sets at JFK International Air Terminal the Virtual Pharma Alliance S.R.L. Reflects on key takeaways from our interactions in the USA this past week… 1. The appetite for deals is as strong as ever, however after the “Biotech bubble” the need for data and details on products and technologies as part of the diligence process is greater than ever 2. Bolt on Vs Diversification - grow the core or branch out? Trends are emerging in subsectors particularly with Pharmaceutical companies and CRDMO’s… 3. Alliances Vs Acquisition - as the VPA has outlined in previous posts this trend to add value without fully absorbing complementary assets is surging, also there are very few total service providers in Pharma and alliances are going to be even more strategic in product development (develop and go - avoid integration dilution, avoid mega commitments to 3rd parties…) We thank all our current and potential customers and alliance partners for their time and look forward to continuing the evolution at CPHI in Milan and beyond! #pharmalution #evolution #strategy #development #r&d Virtual Pharma Alliance S.R.L. #formulation #api #excipient #medicaldevices #packaging #portfolio #usa #growth #new #future #cphi #businessdevelopment

3 of the biggest (but not the only) talking points from our time in the USA this week… Let’s discuss at CPHI info@virtualpharmaalliance.com #pharmalution #evolution #strategy #pharmaceuticals #pharma #productdevelopment #vpa #usa #growth #businessdeveloment #formulation #api #excipient #packaging #medicaldevices #alliances #m&a

That's a wrap on PharmSci 360, and our team is headed back to Laval! While AI-related topics were understandably popular, our team was most excited to see a very thoughtful presentation on predicting intestinal permeability to enable oral drug delivery led by Mark Niosi. Why? Because common issues with permeability, dissolution rates, and more, are often not getting the attention they deserve. We're still finding that too many biotechs are rushing through pre-formulation in a misguided effort to save time and money. Ironically, investing in this part of the process would typically help them save much more of both. Here's an overview of our pre-formulation process: https://hubs.la/Q02QLN4g0 #PharmSci360 #CorealisPharma #CDMO #SolidScience #PharmaceuticalOutsourcing #preformulation

I'm thrilled to highlight the groundbreaking advancements in non-invasive drug testing technology by Intelligent Bio Solutions Inc. (INBS). Their innovative approach leverages sweat technology to provide rapid and intelligent testing solutions. Sweat technology is revolutionizing the field by offering a non-invasive, user-friendly method for drug screening. Unlike traditional methods that rely on blood, saliva, or urine, sweat collection is quick, painless, and less intrusive, making it an ideal solution for various settings, including workplaces, clinics, and law enforcement. INBS is at the forefront of this innovation with their Intelligent Fingerprinting Drug Screening System, which includes a drug screening cartridge, a DSR-Plus fluorescence reader, and a collection kit for laboratory analysis. This cutting-edge system not only simplifies the testing process but also enhances accuracy and reliability. As INBS navigates the FDA 510(k) regulatory pathway, the recent commencement of their pharmacokinetic (PK) study marks a significant milestone. This study will deepen our understanding of opiate metabolism, distribution, and excretion in human sweat, paving the way for broader applications of this technology. Exciting times ahead as we witness the transformation of drug testing through sweat technology, driven by INBS's relentless pursuit of innovation and excellence. #MedicalTechnology #Innovation #NonInvasiveTesting #SweatTechnology #DrugScreening #HealthcareInnovation #INBS

Looking for a CDMO that stands out from the crowd? At TCG Lifesciences, we're not just another CDMO. We're a dynamic force redefining the landscape of life sciences with innovation and dedication. 🔍 What sets us apart? 1️⃣ Tailored Solutions: We understand that every project is unique. That's why we offer customized solutions to meet your specific needs, ensuring maximum efficiency and success. 2️⃣ End-to-End Expertise: From discovery to commercialization, we've got you covered. Our comprehensive services span the entire drug development continuum, streamlining the process and accelerating timelines. 3️⃣ Collaborative Partnership: Your success is our priority. We believe in fostering collaborative partnerships built on trust, transparency, and open communication. Together, we'll achieve remarkable results. 4️⃣ Cutting-Edge Technology: Innovation drives us forward. We invest in state-of-the-art technology and continuously strive to push the boundaries of scientific advancement. 5️⃣ Global Reach, Local Presence: With a global footprint and local expertise, we offer the best of both worlds. Wherever you are, we're there to support your journey. Experience the TCG Lifesciences difference and unlock the full potential of your projects. Let's innovate together and shape the future of healthcare. To learn more, please contact at Ritu.mishra@tcgls.com. #TCGLifesciences #CDMO #Innovation #Pharmaceuticals #Biotech #LifeSciences #Partnership #Collaboration

High Beam Global's recent research project delved into the dynamic CRO/CDMO market, focusing on trends in outsourcing activities by Indian Pharma/Biotech companies. Our team conducted 20 expert interviews in just 2 weeks, engaging Business Development and Sales Directors. Our two-step validation process ensured accuracy, mapping experts using our proprietary database and validating profiles via phone screening. Leveraging HBG's insightful research, gain invaluable knowledge and explore the future possibilities that await your brand within the dynamic world of market trends. To delve deeper into the world of #HBGKnowledge, visit https://lnkd.in/f9mN6BS #CRO #CDMO #MarketTrends #ResearchExcellence #BusinessInsights #InnovationLeaders #HighBeamGlobal #StrategicAnalysis #FuturePossibilities #marketintelligence #ExpertInterviews #QualityResearch #BrandStrategy #DynamicSolutions

Dear #Linkedinfamily Stay informed with the latest updates! Catch our news bulletin for breaking news, in-depth analysis, and exclusive stories. Follow us to stay ahead and never miss out on important news. Strata Skin Sciences’ XTRAC Momentum 1.0 device receives Japanese approval Click the Link Below for More & Detailed Info: https://lnkd.in/gp8Nwe-C Follow us for real-time updates and in-depth analysis. Lifescience Intellipedia Pvt. Ltd. Chemxpert Database #lifescienceintellipedia #lifesciences #chemxpert #chemxpertdatabase #database #daily #new #PharmaNews #PharmaUpdates #BiotechNews #PharmaInnovation #PharmaResearch #MedicalResearch #PharmaIndustry #NewMedication #PharmaTrends #Biopharma #PharmaTech

Milan is preparing to host CPHI 2024, the international event for the pharmaceutical industry, from 8 to 10 October. It is the ideal opportunity to explore the entire supply chain and discover technologies. ✅ In terms of technology, we at Retinae will be present with our brand new CS150 carton serialisation solution, which features a high-performance camera connected to an ejection system for products where the vision software detects defects or non-conformities. The system is also modular, allowing users to include or exclude specific components such as the tamper-evident station, vignette and scale. The Retinae's CS150 is a perfect system to meet the needs of small and medium sized pharmaceutical companies producing small to medium volumes but with very repetitive and frequent production. The CS150 allows quick and easy format changeovers. This allows small batches of different products to be handled. ✅ Visit us at stand 18H33, we will be there with MONOLAB S.R.L. and Kikusui Electronics Corporation #CPHI2024 #PharmaInnovation #Serialisation #PharmaSupplyChain #MachineVision #retinae #IndustrialAutomation #PharmaceuticalIndustry #QualityControl #qualityassurance #CPHI #CPHIMILAN

Drug discovery

Personalized medicine, clinical chemistry, or even criminology: Diagnostics is becoming increasingly important in modern medicine. The biggest challenge? Expertise that goes far beyond filling and closing. High-tech solutions are needed. That’s why Optima specializes in the development of turnkey solutions and takes central responsibility with multiple systems from one source. “Our diagnostic customers benefit from the experience and expertise we have gained over many years of providing turnkey solutions to the pharmaceutical industry. This ensures a strong and well-established technical foundation for such tasks," says Christian Müller, Director Sales Diagnostic Global at Optima Pharma. Read the whole expert interview in the latest issue of o-com diagnostic, Page 8 - 13 ▶️ https://lnkd.in/eRWNDUDC #optima #wecareforpeople #pharma #diagnostic #medicine #turnkey